NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells

Overview of attention for article published in Breast Cancer Research and Treatment, October 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 183 Dimensions

Readers on

mendeley: 77 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

METHODS OF TREATMENT OF CANCER DISEASE BY TARGETING AN EPIGENETIC FACTOR

Application WO-2021156329-A1

World Intellectual Property Organisation (WIPO)

Method for cancer cell reprogramming

Grant US-10039771-B2

United States of America

Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem…

Grant US-9675576-B2

United States of America

METHODS AND USE OF COMPOUNDS THAT BIND TO RELA OF NF-KB

Application WO-2016196664-A1

World Intellectual Property Organisation (WIPO)

Method for cancer cell reprogramming

Grant US-9314460-B1

United States of America